Karen Smith
About
Karen Smith is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Karen Smith has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karen Smith's work include Cardiac Imaging and Diagnostics (8 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Myocardial Infarction Research (6 papers). Karen Smith is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Myocardial Infarction Research (6 papers). Karen Smith collaborates with scholars based in United States, Canada and United Kingdom. Karen Smith's co-authors include Carl J. Pepine, C. Noel Bairey Merz, George Sopko, B. Delia Johnson, Eileen Handberg, Barry L. Sharaf, Steven E. Reís, R. David Anderson, Richard A. Kerensky and Gregory O. von Mering and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes.
In The Last Decade
Karen Smith
36 papers receiving 1.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Karen Smith United States | 17 | 1.4k | 907 | 626 | 175 | 96 | 36 | 1.9k | ||
| Wan Azman Wan Ahmad Malaysia | 24 | 1.2k 0.9× | 382 0.4× | 896 1.4× | 106 0.6× | 55 0.6× | 103 | 1.9k | ||
| Ahmet Kaya Türkiye | 19 | 638 0.5× | 190 0.2× | 203 0.3× | 81 0.5× | 32 0.3× | 118 | 1.2k | ||
| Jerry V. Glowniak United States | 17 | 397 0.3× | 391 0.4× | 350 0.6× | 207 1.2× | 29 0.3× | 33 | 1.3k | ||
| Galen Cook‐Wiens United States | 20 | 538 0.4× | 405 0.4× | 393 0.6× | 114 0.7× | 130 1.4× | 88 | 1.4k | ||
| Evandro Tinoco Mesquita Brazil | 20 | 1.0k 0.8× | 127 0.1× | 794 1.3× | 82 0.5× | 161 1.7× | 196 | 2.5k | ||
| Thomas Andrews United States | 23 | 1.4k 1.0× | 356 0.4× | 732 1.2× | 313 1.8× | 177 1.8× | 39 | 2.3k | ||
| Jorge Wong Canada | 18 | 940 0.7× | 198 0.2× | 189 0.3× | 119 0.7× | 25 0.3× | 67 | 1.3k | ||
| Lori Mandelzweig Israel | 21 | 857 0.6× | 190 0.2× | 347 0.6× | 341 1.9× | 90 0.9× | 41 | 1.6k | ||
| Gerard C.M. Linssen Netherlands | 30 | 2.5k 1.9× | 461 0.5× | 1.4k 2.3× | 341 1.9× | 48 0.5× | 122 | 3.3k | ||
| Otávio Gebara Brazil | 19 | 550 0.4× | 113 0.1× | 205 0.3× | 378 2.2× | 107 1.1× | 62 | 1.3k |
Countries citing papers authored by Karen Smith
Since
Specialization
Citations
This map shows the geographic impact of Karen Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Smith more than expected).
Fields of papers citing papers by Karen Smith
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Karen Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Smith. The network helps show where Karen Smith may publish in the future.
Co-authorship network of co-authors of Karen Smith
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Smith. A scholar is included among the top collaborators of Karen Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Smith. Karen Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Smith, Karen, et al.. (2019). DIY productive failure: boosting performance in a large undergraduate biology course. npj Science of Learning. 4(1). 1–1.
2.
Yun, Brian J., Stephen C. Dorner, John A. Brennan, et al.. (2017). Attending documentation contribution to billing at an academic ED with an electronic health record. The American Journal of Emergency Medicine. 35(10). 1494–1496.
3.
Swartz, Michael F., Karen Smith, Franca Kraenzlin, et al.. (2016). Costs and Outcomes in the Care of Bi-ventricular Support as a Bridge to Cardiac Transplant. ASAIO Journal. 62(5). 513–517.
4.
Nagueh, Sherif F., Bertron Μ. Groves, Leonard Schwartz, et al.. (2011). Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy. Journal of the American College of Cardiology. 58(22). 2322–2328.
5.
Pepine, Carl J., R. David Anderson, Barry L. Sharaf, et al.. (2010). Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia. Journal of the American College of Cardiology. 55(25). 2825–2832.
6.
McCrae, Christina S., et al.. (2010). Comparison of Actigraphic and Subjective Measures of Sleep in Implantable Cardioverter Defibrillator and Coronary Artery Disease Patients. Clinical Cardiology. 33(12). 753–759.
7.
Ahmed, Bina, C. Noel Bairey Merz, B. Delia Johnson, et al.. (2008). Diabetes Mellitus, Hypothalamic Hypoestrogenemia, and Coronary Artery Disease in Premenopausal Women (from the National Heart, Lung, and Blood Institute Sponsored WISE Study). The American Journal of Cardiology. 102(2). 150–154.
8.
Wessel, Timothy R., Christopher B. Arant, Susan P. McGorray, et al.. (2007). Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE). Clinical Cardiology. 30(2). 69–74.
9.
Pepine, Carl J., Richard A. Kerensky, Charles R. Lambert, et al.. (2006). Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease. Journal of the American College of Cardiology. 47(3). S30–S35.
10.
Arant, Christopher B., Timothy R. Wessel, Marian B. Olson, et al.. (2004). 847-6 Serum inflammatory markers correlate with hemoglobin levels in women undergoing evaluation for suspected ischemia: Results from the national heart, lung, and blood institute WISE study. Journal of the American College of Cardiology. 43(5). A515–A515.
11.
Shepherd, James, Chris J. Packard, Thomas Littlejohn, et al.. (2004). Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy*. Current Medical Research and Opinion. 20(10). 1571–1578.
12.
Smith, Karen. (2004). Heart Disease in Women. Circulation. 109(18).
13.
Morise, Anthony P., Marian B. Olson, C. Noel Bairey Merz, et al.. (2004). Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. American Heart Journal. 147(6). 1085–1092.
14.
Bartholomew, Beth A., et al.. (2004). A population‐based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non‐ST elevation myocardial infarction. Clinical Cardiology. 27(2). 74–78.
15.
Arant, Christopher B., Timothy R. Wessel, Marian B. Olson, et al.. (2004). Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain. Journal of the American College of Cardiology. 43(11). 2009–2014.
16.
Durrington, Paul N., Jaakko Tuomilehto, A. Hamann, David Kallend, & Karen Smith. (2004). Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia. Diabetes Research and Clinical Practice. 64(2). 137–151.
17.
Smith, Karen & Ben M. Lomaestro. (2003). What Role do Fluoroquinolone Antimicrobial Agents Play in Cardiac Dysfunction and Altered Glycemic Control?. Journal of Pharmacy Practice. 16(5). 349–360.
18.
Holubkov, Richard, Carl J. Pepine, Nathaniel Reichek, et al.. (2002). Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the nhlbi wise study. Clinical Cardiology. 25(12). 553–558.
19.
Sehgal, Varun, Zuofeng Li, Jatinder Palta, Karen Smith, & Wesley E. Bolch. (2002). Application of imaging‐derived parameters to dosimetry of intravascular brachytherapy sources: Perturbation effects of residual plaque burden. Medical Physics. 29(7). 1580–1589.
20.
Benson, Blaine E., et al.. (2000). Toxicities and outcomes associated with nefazodone poisoning: An analysis of 1,338 exposures. The American Journal of Emergency Medicine. 18(5). 587–592.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Wan Azman Wan Ahmad Breakdown of academic impact, for papers by Ahmet Kaya Breakdown of academic impact, for papers by Jerry V. Glowniak Breakdown of academic impact, for papers by Galen Cook‐Wiens Breakdown of academic impact, for papers by Evandro Tinoco Mesquita Breakdown of academic impact, for papers by Thomas Andrews Breakdown of academic impact, for papers by Jorge Wong Breakdown of academic impact, for papers by Lori Mandelzweig Breakdown of academic impact, for papers by Gerard C.M. Linssen Breakdown of academic impact, for papers by Otávio Gebara